Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
14,803,113
-
Share change
-
+5,953,658
-
Total reported value
-
$25,298,000
-
Price per share
-
$1.71
-
Number of holders
-
16
-
Value change
-
+$10,138,667
-
Number of buys
-
8
-
Number of sells
-
5
Institutional Holders of SOLENO THERAPEUTICS INC - COM NEW (SLNO) as of Q4 2018
As of 31 Dec 2018,
SOLENO THERAPEUTICS INC - COM NEW (SLNO) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,803,113 shares.
The largest 10 holders included
Abingworth LLP, Vivo Capital, LLC, ORACLE INVESTMENT MANAGEMENT INC, 683 Capital Management, LLC, SABBY MANAGEMENT, LLC, Vanguard Group Inc, Fosun International Ltd, Trellus Management Company, LLC, DIMENSIONAL FUND ADVISORS LP, and BlackRock Inc..
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.